Craig R. Jalbert
President, Secretary, Principal Executive, Financial and Accounting Officer & DirectorMr. Craig R. Jalbert, CIRA, is President, Treasurer, Corporate Secretary, Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer & Director of Getaround, Inc. from August 26, 2026. He is CEO, President, Corporate Treasurer, Corporate Secretary & Director of T2 Biosystems, Inc. from April 3, 2025. He is Director of CohBar, Inc. from November 6, 2023. He served as President, Corporate Secretary & Director of Unity Biotechnology, Inc. from June 27, 2025. He served as President, CEO, Treasurer, Secretary & Director at Oncternal Therapeutics, Inc. since July 2025. He was CEO, President, CFO, Treasurer, Corporate Secretary & Director of Viracta Therapeutics, Inc. from February 2025. Mr. Jalbert served as a CEO, President, Chief Financial Officer, Treasurer and Secretary and sole member of the board since November 2024 at TFF Pharmaceuticals, Inc. He was President, Treasurer, CS, Principal Executive Officer, Financial Officer, & Principal Accounting Officer of NexImmune, Inc. from August 27, 2024. He was Chief Executive Officer, President, Treasurer, Secretary and Director of TRACON Pharmaceuticals, Inc. from July 31, 2024. He served as President, Chief Executive Officer, Treasurer, Secretary and Director of eFFECTOR Therapeutics, Inc. since June 2024. He served as President, Corporate Secretary, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer at Evelo Biosciences, Inc. since November 21, 2023 and served as its Director since November 20, 2023. Mr. Jalbert served as President, Treasurer, Corporate Secretary, principal executive officer, principal financial officer, principal accounting officer & Director at Bellerophon Therapeutics, Inc. since November 15, 2023. He served as Director at Oncorus, Inc. since July 28, 2023 and served as Chief Executive Officer, President, Chief Financial Officer, Treasurer and Secretary from August 4, 2023. He served as President, Treasurer, Corporate Secretary, Chief Executive Officer, Accounting and Financial Officer & Director at Axcella Health Inc. since November 02, 2023. He was President, Treasurer, Corporate Secretary & Director of Aptinyx Inc. since May 04, 2023 and was its Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer since June 30, 2023. He was President, Treasurer, Corporate Secretary, Principal Executive Officer, Interim Principal Financial and Accounting Officer and Director of Rubius Therapeutics, Inc. from March 4, 2023. He served as the President, Treasurer, Secretary and Director of Dendreon Corp. since June 10, 2015. Mr. Jalbert had been the President, Secretary and Treasurer of Cambridge Heart Inc. since January 21, 2014. Mr. Jalbert has been Company Secretary of MZT Holdings, Inc. since January 18, 2008 and served as its President and Treasurer. He served as a Principal of Verdolino & Lowey, P. C., an accounting firm that specializes in working with companies liquidating and winding up their operations. Mr. Jalbert served as the President, Chief Administrative Officer, Treasurer and Secretary of IBIS Technology Corp., since February 17, 2009. Mr. Jalbert joined Verdolino & Lowey in 1987. Prior to joining V&L, Mr. Jalbert served as a Senior Auditor, Commercial Audit Division of Arthur Anderson & Co. He had been a Director of Cambridge Heart Inc. since January 21, 2014 and MZT Holdings, Inc., (f/k/a Matritech, Inc.), since January 22, 2008. Mr. Jalbert served on the Board of Directors of RNI Winddown Corporation, (f/k/a Riverstone Networks, Inc.). He served as a Director of IBIS Technology Corp., since February 17, 2009. Mr. Jalbert has served as a principal of the Foxborough, Massachusetts accounting firm of Verdolino & Lowey, P.C. since 1987. For over 30 years he has focused his practice in distressed businesses and has served and continues to serve, in the capacities of officer and director for numerous firms in their wind-down phases.
Positions
- Company NameEvelo Biosciences, Inc.Stock CodeEVLOPositionPresident, Secretary, Principal Executive, Financial and Accounting Officer & Director
- Company NameT2 Biosystems, Inc.Stock CodeTTOOPositionCEO, President, Corporate Treasurer, Corporate Secretary & DirectorColleagues
- CRCraig R. JalbertCEO, President, Corporate Treasurer, Corporate Secretary & Director
- KJKelley J. MorganChief People Officer
- BABrett A. GiffinChief Commercial Officer
- RSRoger SmithSenior Vice President of Science Research & Development
- PGPeter G. PappasMember of Clinical Advisory Board
- ESEric S. RosenbergMember of Clinical Advisory Board
- LBLouis B. RiceMember of Clinical Advisory Board
- MAMichael A. PfallerMember of Clinical Advisory Board
- Company NameGetaround, Inc.Stock CodeGETRPositionPresident, Treasurer, Corp. Sec., Principal Exec., Financial & Accounting Officer and Director
